TTCI Congratulates Lect. Dr. Suyanee Thongchot on Receiving DMSc First Prize Award and Outstanding Alumni Award 2026
October 16, 2026
BANGKOK, THAILAND – The Thailand Hub of Talents in Cancer Immunotherapy (TTCI) proudly congratulates Lect. Dr. Suyanee Thongchot (อาจารย์ ดร.สุญาณี ทองโชติ) from the Department of Immunology, Faculty of Medicine Siriraj Hospital, Mahidol University, on receiving two prestigious awards recognizing her outstanding achievements in medical science research, innovation, and academic excellence.
First Prize at the DMSc Awards for Cancer Vaccine Innovation
Lect. Dr. Suyanee Thongchot received the 1st Prize in the Medical Science Research and Development Category at the DMSc Awards for her innovative research project entitled:
"Peptide Vaccine Innovation to Stimulate Specific T Cells Against Mesothelin and Nucleolin for Breast Cancer Treatment"
Thai Research Title:
"นวัตกรรมวัคซีนเปปไทด์เพื่อกระตุ้นทีเซลล์จำเพาะต่อมีโซทีลินและนิวคลีโอลินสำหรับการรักษาโรคมะเร็งเต้านม"
The research focuses on developing an innovative peptide-based cancer vaccine designed to stimulate specific T-cell responses against Mesothelin and Nucleolin, two molecular targets relevant to breast cancer immunotherapy.
This achievement highlights the potential of T-cell-directed vaccine strategies to advance cancer immunotherapy research and support the development of innovative therapeutic approaches.
In recognition of this outstanding accomplishment, Lect. Dr. Suyanee was presented with a commemorative plaque graciously bestowed by Professor Dr. Her Royal Highness Princess Chulabhorn Krom Phra Srisavangavadhana during the opening ceremony of the Annual Medical Sciences Conference.
Outstanding Alumni Award in Research and Technology 2026
In addition to her achievement at the DMSc Awards, Lect. Dr. Suyanee Thongchot was honored with the Outstanding Alumni Award in Research and Technology (2026), conferred by the Faculty of Associated Medical Sciences, Khon Kaen University.
This recognition celebrates her contributions to scientific research, technological innovation, and the advancement of medical sciences, reflecting her dedication to translating research discoveries into meaningful scientific progress.
Advancing Cancer Immunotherapy Research in Thailand
These two prestigious honors reflect Lect. Dr. Suyanee's commitment to advancing innovative cancer immunotherapy approaches, particularly the development of peptide vaccines and T-cell-targeted therapeutic strategies.
Her achievements also demonstrate the growing capabilities of Thai researchers in developing novel immunotherapeutic approaches and contributing to the international scientific community.
Celebrating Research Excellence and Scientific Innovation
The Thailand Hub of Talents in Cancer Immunotherapy (TTCI) extends its warmest congratulations to Lect. Dr. Suyanee Thongchot on receiving these distinguished awards.
These recognitions highlight her dedication, research excellence, and contributions to the advancement of cancer immunotherapy and medical science innovation in Thailand.
TTCI proudly celebrates this remarkable achievement and remains committed to supporting scientific excellence, collaborative research, and the development of innovative cancer immunotherapies for the future.
Official Website: www.ttci-th.org
First Prize at the DMSc Awards for Cancer Vaccine Innovation
Lect. Dr. Suyanee Thongchot received the 1st Prize in the Medical Science Research and Development Category at the DMSc Awards for her innovative research project entitled:
"Peptide Vaccine Innovation to Stimulate Specific T Cells Against Mesothelin and Nucleolin for Breast Cancer Treatment"
Thai Research Title:
"นวัตกรรมวัคซีนเปปไทด์เพื่อกระตุ้นทีเซลล์จำเพาะต่อมีโซทีลินและนิวคลีโอลินสำหรับการรักษาโรคมะเร็งเต้านม"
The research focuses on developing an innovative peptide-based cancer vaccine designed to stimulate specific T-cell responses against Mesothelin and Nucleolin, two molecular targets relevant to breast cancer immunotherapy.
This achievement highlights the potential of T-cell-directed vaccine strategies to advance cancer immunotherapy research and support the development of innovative therapeutic approaches.
In recognition of this outstanding accomplishment, Lect. Dr. Suyanee was presented with a commemorative plaque graciously bestowed by Professor Dr. Her Royal Highness Princess Chulabhorn Krom Phra Srisavangavadhana during the opening ceremony of the Annual Medical Sciences Conference.
Outstanding Alumni Award in Research and Technology 2026
In addition to her achievement at the DMSc Awards, Lect. Dr. Suyanee Thongchot was honored with the Outstanding Alumni Award in Research and Technology (2026), conferred by the Faculty of Associated Medical Sciences, Khon Kaen University.
This recognition celebrates her contributions to scientific research, technological innovation, and the advancement of medical sciences, reflecting her dedication to translating research discoveries into meaningful scientific progress.
Advancing Cancer Immunotherapy Research in Thailand
These two prestigious honors reflect Lect. Dr. Suyanee's commitment to advancing innovative cancer immunotherapy approaches, particularly the development of peptide vaccines and T-cell-targeted therapeutic strategies.
Her achievements also demonstrate the growing capabilities of Thai researchers in developing novel immunotherapeutic approaches and contributing to the international scientific community.
Celebrating Research Excellence and Scientific Innovation
The Thailand Hub of Talents in Cancer Immunotherapy (TTCI) extends its warmest congratulations to Lect. Dr. Suyanee Thongchot on receiving these distinguished awards.
These recognitions highlight her dedication, research excellence, and contributions to the advancement of cancer immunotherapy and medical science innovation in Thailand.
TTCI proudly celebrates this remarkable achievement and remains committed to supporting scientific excellence, collaborative research, and the development of innovative cancer immunotherapies for the future.
Official Website: www.ttci-th.org
